Phase II and pharmacodynamic study of the farnesyltransferase inhibitor R115777 as initial therapy in patients with metastatic pancreatic adenocarcinoma
Steven J. Cohen, Linus Ho, Sulabha Ranganathan, James L. Abbruzzese, R. Katherine Alpaugh, Mary Beard, Nancy L. Lewis, Susan McLaughlin, André Rogatko, Juan J. Perez-Ruixo, Amanda M. Thistle, Tom Verhaeghe, Hao Wang, Louis M. Weiner, John J. Wright, Gary R. Hudes, Neal J. Meropol
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Phase II and pharmacodynamic study of the farnesyltransferase inhibitor R115777 as initial therapy in patients with metastatic pancreatic adenocarcinoma'. Together they form a unique fingerprint.